Novartis Gene Therapies, Inc. et al. v. Aventis, Inc. et al. > Summary
Court Case Number IPR2023-01045
Filing Date Jun 30, 2023
Court Patent Trial and Appeal Board
Status Trial Instituted
Administrative JudgesSheridan K. Snedden, Jeffrey N. Fredman, James A. Tartal
Judge Writing the Final DecisionSheridan K. Snedden
Claims Challenged in the Petition: 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
Claims Instituted: 5, 6, 7, 8, 9, 15, 16
Petitioner
Petitioner Attorneys
5Novartis Gene Therapies, Inc.
Attorney Name: John D. Livingstone
Finnegan, Henderson, Farabow, Garrett & Dunner
Novartis Gene Therapies, Inc.
Attorney Name: Amanda K. Murphy
Finnegan, Henderson, Farabow, Garrett & Dunner
Novartis Gene Therapies, Inc.
Attorney Name: Jeffrey D. Smyth
Finnegan, Henderson, Farabow, Garrett & Dunner
Novartis
Attorney Name: Steven Berkowitz
Etehad Law, APC
Novartis Gene Therapies, Inc.
Attorney Name: William Esper
Finnegan, Henderson, Farabow, Garrett & Dunner
Patent Owner Attorneys
5Sanofi
Attorney Name: David E. Wilks
Wilks Law Firm
Sanofi
Attorney Name: Jeffrey E. Hansen
Wilks Law Firm
Sanofi
Attorney Name: Amanda K. Antons
Dechert
Sanofi
Attorney Name: Blaine M. Hackman
Dechert
Sanofi
Attorney Name: Katherine A. Helm
Dechert
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 10429288 | Analytical ultracentrifugation for characterization of recombinant viral particles | Oct 1, 2019 |
